One Stop Shop for All Your Market Research Reports

Global Market Study on Compounding Pharmacies: Regulatory Harmonization and Innovative Therapeutic Areas to Boost Demand for Compounded Drugs

Compounding Pharmacies are pharmacies that produce drugs tailored to needs of individual patients, by altering, combining, or mixing active pharmaceutical ingredients of drugs. Compounded drugs are prepared under prescription from physicians. Compounding includes the combination of two or more drug ingredients in varied proportions. Most regulatory agencies across the world do not approve compounded medications and do not verify the safety or effectiveness of compounded drugs. These drugs are mostly not reimbursed by pharmaceutical benefits agencies. The global compounding pharmacies market report deals with compounded drugs, which are customized medicines, prepared by a pharmacist, or a physician and are available in strengths not commercially available. These medicines are easily available at community pharmacies and are known to provide personalized relief. Compounded drugs are available in various forms such as oral applications (capsules, mixtures, etc.), topical applications (creams, gels, lotions, ointments, etc.), and suppositories. These drugs can be formulated for both human beings and animals. The global compounded drug market is expected to expand at a CAGR of 6% over the forecast period (2015?2021) to account for US$ 9,751 Mn by 2021.
Inquiry Before Buying
Request Sample
To choose the report type and your desired payment method

Share This Report

Our Clients

Latest Market News

Total – Maersk Deal Sees Total Buying Maersk Oil Business

A Total - Maersk deal has led to Total buying the Maersk oil operation for $7.45 Billion (£5.8 bn).  Maersk Oil is a Danish company that has the concession for the exploration and production of oil and gas in the Danish sector of the North Sea.  By purchasing Maersk, the French oil giant Total has suddenly become th [...]

Read More
BHP Billiton Shale Assets to be Sold Through Elliot Management Pressure

BHP Billiton US shale assets in the US are to be sold. The decision was made after the Australian mining company declared a net profit of $5.89 billion. Although this result was lower than analysts expected it was still better than last year. The global mining firm made a record loss in 20176 of $6.39 billion.   [...]

Read More
US Car Production and the Japanese Syndrome

US car production is gradually slowing down.  Ford SUV sales in July 2017 have increased by 2.2% over July, 2016. However, overall auto sales were down 7.4% for the same July. How is this, and what can be done to ensure non-SUV sales maintain a high position in the market?   The so-called ‘Japanese syndro [...]

Read More
US Factory Output Drops in July Through Falling Car Production

US factory output dropped in July according to the Federal Reserve.  The main reason for this was ascribed to falling car production. While factory output dropped by 0.1%, overall production increased by 0.2%.  This figure includes mining and utilities, increasing by 0.5% and 1.6% respectively.   This info [...]

Read More
US-China Trade Relationship in Jeopardy Through Trump’s Actions

Further to our recent news article “Is the US-China Trade Relationship in Jeopardy?” the US has now launched an official investigation into China’s use of ‘intellectual property.’ The US-China Trade Relationship appears to be in trouble regarding China’s use of counterfeit goods and pirated software. &nb [...]

Read More
Payment Mode
Single User $ 4900
Multi User $7600
Corporate User $10600
About this Report
Report ID 13007
Category
  • Biotechnology
Published on 12-Oct
Number of Pages 160
Publisher Name Persistence Market Research
Over all Rating
"Rating is based on 14 reviews"